Register      Login
Journal of Primary Health Care Journal of Primary Health Care Society
Journal of The Royal New Zealand College of General Practitioners
RESEARCH ARTICLE (Open Access)

Can SSRI’s help women suffering with PMS?

Vanessa Jordan https://orcid.org/0000-0002-9079-6457 1 *
+ Author Affiliations
- Author Affiliations

1 Department Obstetrics and Gynaecology, Grafton Campus, University of Auckland, Auckland, New Zealand.

* Correspondence to: v.jordan@auckland.ac.nz

Journal of Primary Health Care 16(3) 317-318 https://doi.org/10.1071/HC24135
Submitted: 2 September 2024  Accepted: 2 September 2024  Published: 9 September 2024

© 2024 The Author(s) (or their employer(s)). Published by CSIRO Publishing on behalf of The Royal New Zealand College of General Practitioners. This is an open access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND)

References

Jespersen C, Lauritsen MP, Frokjaer VG, et al. Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder. Cochrane Database Syst Rev [8] 2024; CD001396.
| Crossref | Google Scholar | PubMed |

Liu X, Li R, Wang S, et al. Global, regional, and national burden of premenstrual syndrome, 1990-2019: an analysis based on the Global Burden of Disease Study 2019. Hum Reprod 2024; 39(6): 1303-1315.
| Crossref | Google Scholar | PubMed |

World Health Organization. ICD-11: International classification of diseases (11th revision). 2022. Available at https://icd.who.int/

Miller KN, Standeven L, Morrow AL, et al. GABAergic neuroactive steroid response to sertraline in premenstrual dysphoric disorder. Psychoneuroendocrinology 2024; 160: 106684.
| Crossref | Google Scholar | PubMed |